FIELD: chemistry.
SUBSTANCE: invention relates to steroid ligands for use in nuclear receptor-based inducible gene expression systems. The invention also relates to methods of modulating the expression of genes of interest using a system containing one or more nuclear receptor complexes and one or more steroid ligands. Other aspects include ligand compositions including therapeutic compositions.
EFFECT: improved method.
21 cl, 1 ex, 9 tbl, 20 dwg
Authors
Dates
2013-07-10—Published
2009-03-16—Filed